Fisk JD - Search Results

1

The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada.

Marrie RA, Fisk JD, Stadnyk KJ, Yu BN, Tremlett H, Wolfson C, Warren S, Bhan V; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis. Marrie RA, et al. Among authors: fisk jd. Can J Neurol Sci. 2013 Nov;40(6):824-31. Can J Neurol Sci. 2013. PMID: 24257224

2

Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients.

Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE, Murray TJ. Archibald CJ, et al. Among authors: fisk jd. Pain. 1994 Jul;58(1):89-93. doi: 10.1016/0304-3959(94)90188-0. Pain. 1994. PMID: 7970843 Clinical Trial.

3

Hospital-based psychiatric service utilization and morbidity in multiple sclerosis.

FisK JD, Morehouse SA, Brown MG, Skedgel C, Murray TJ. FisK JD, et al. Can J Neurol Sci. 1998 Aug;25(3):230-5. doi: 10.1017/s0317167100034065. Can J Neurol Sci. 1998. PMID: 9706725

4

Prevalence of cognitive impairment and dementia as defined by neuropsychological test performance.

Larrea FA, Fisk JD, Graham JE, Stadnyk K. Larrea FA, et al. Among authors: fisk jd. Neuroepidemiology. 2000 May-Jun;19(3):121-9. doi: 10.1159/000026247. Neuroepidemiology. 2000. PMID: 10705230

5

Short term predictors of unemployment in multiple sclerosis patients.

Busche KD, Fisk JD, Murray TJ, Metz LM. Busche KD, et al. Among authors: fisk jd. Can J Neurol Sci. 2003 May;30(2):137-42. doi: 10.1017/s0317167100053403. Can J Neurol Sci. 2003. PMID: 12774953

6

A comparison of health utility measures for the evaluation of multiple sclerosis treatments.

Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. Fisk JD, et al. J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):58-63. doi: 10.1136/jnnp.2003.017897. J Neurol Neurosurg Psychiatry. 2005. PMID: 15607996 Free PMC article.

7

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS. Brown MG, et al. Among authors: fisk jd. Neurology. 2007 Oct 9;69(15):1498-507. doi: 10.1212/01.wnl.0000271884.11129.f3. Epub 2007 Aug 15. Neurology. 2007. PMID: 17699802

8

Social anxiety in a multiple sclerosis clinic population.

Poder K, Ghatavi K, Fisk JD, Campbell TL, Kisely S, Sarty I, Stadnyk K, Bhan V. Poder K, et al. Among authors: fisk jd. Mult Scler. 2009 Mar;15(3):393-8. doi: 10.1177/1352458508099143. Epub 2008 Nov 21. Mult Scler. 2009. PMID: 19028833 Free article.

9

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.

Veugelers PJ, Fisk JD, Brown MG, Stadnyk K, Sketris IS, Murray TJ, Bhan V. Veugelers PJ, et al. Among authors: fisk jd. Mult Scler. 2009 Nov;15(11):1286-94. doi: 10.1177/1352458509350307. Epub 2009 Oct 30. Mult Scler. 2009. PMID: 19965558

10

Butyrylcholinesterase activity in multiple sclerosis neuropathology.

Darvesh S, Leblanc AM, Macdonald IR, Reid GA, Bhan V, Macaulay RJ, Fisk JD. Darvesh S, et al. Among authors: fisk jd. Chem Biol Interact. 2010 Sep 6;187(1-3):425-31. doi: 10.1016/j.cbi.2010.01.037. Epub 2010 Feb 1. Chem Biol Interact. 2010. PMID: 20122907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters